SCHEMBL18174858

SCHEMBL18174858

Cc1cccc(Cc2cccc(O)c2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.64
IDH1 O75874 2/20 0.53
ENPP2 Q13822 1/20 0.52
IDO1 P14902 2/20 0.52
CHRM2 P08172 1/20 0.48
CHRM1 P11229 1/20 0.48
CHRM3 P20309 1/20 0.48
TAAR1 Q96RJ0 2/20 0.48
DRD2 P14416 1/20 0.48
DRD1 P21728 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
PKM P14618 1/20 0.47
ALOX15 P16050 1/20 0.47
NFKB1 P19838 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.46
HSD17B1 P14061 1/20 0.46
HSD17B2 P37059 1/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70267 0.87 ENPP2 (0.65) IDH1ENPP2CHRM2CHRM1CHRM3
SCHEMBL30979264 0.87 ENPP2 (0.65) IDH1ENPP2CHRM2CHRM1CHRM3
SCHEMBL29459538 0.87 TAAR1 (0.60) ACHEIDO1TAAR1MAPK1DAO
SCHEMBL30000562 0.87 TAAR1 (0.60) ACHEIDO1TAAR1MAPK1DAO
SCHEMBL1263547 0.87 TAAR1 (0.60) ACHEIDO1TAAR1MAPK1DAO
SCHEMBL17243694 0.86 IDH1 (0.51) ACHEIDH1ENPP2CHRM2CHRM1
SCHEMBL6288838 0.86 ESR1 (0.56) ACHEIDH1IDO1TAAR1CYP1A2
SCHEMBL6400232 0.83 ALOX5 (0.49) ACHEIDO1TAAR1CYP1A2CYP3A4
SCHEMBL8093804 0.82 TAAR1 (0.56) ACHEIDH1IDO1TAAR1DAO
SCHEMBL26300969 0.81 ACHE (0.55) ACHEENPP2IDO1CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518766-B2 Tricyclic compound, preparation method therefor and use thereof SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD. (CN) 2022-12-06 US disclosed
US-9477148-B1 Polymer, method for preparing the same, and a photosensitive resin composition thereof INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2016-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11518766-B2 Tricyclic compound, preparation method therefor and use thereof TFPI, TFPI2, F11 ACHE 1761/4885IDH1 3254/4885ENPP2 213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.